Dergiler / Turkish Journal of Veterinary and Animal Sciences / 2020 / Cilt: 44 - Sayı: 3

Assessment of mitogen-activated protein kinases as therapeutic targets for the treatment of babesiosis and theileriosis

Sayfa
702–713
Yayın Tarihi
2020-06-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Furthermore, the structural differences between Prioplasmida and mammalian MAPKs could be a way for researchers to better instigate selective drug design.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:The Piroplasmida order comprises parasitic protozoa including the Theileria and Babesia species that are transmitted by vector ticks and can cause severe diseases in domestic and wild animals.
📊
Temel Bulgular & Veri:Because of limited therapies and available drug resistance, the discovery of new, effective, and safer drugs for veterinary use is important.
💡
Sonuç & Katkı:Furthermore, the structural differences between Prioplasmida and mammalian MAPKs could be a way for researchers to better instigate selective drug design.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Mitogen-activated protein kinase · computer-aided drug design · theileriosis

Abstract

The Piroplasmida order comprises parasitic protozoa including the Theileria and Babesia species that are transmitted by vector ticks and can cause severe diseases in domestic and wild animals. Because of limited therapies and available drug resistance, the discovery of new, effective, and safer drugs for veterinary use is important. Mitogen-activated protein kinases MAPK are a group of serine-threonine protein kinases found in diverse species, including animals and protozoa that conduct vital cellular functions. Therefore, they have been at the centre of drug design studies for many years. Computer-aided structure-based drug design is a fast and effective way in drug discovery efforts to identify candidate compounds. In this study, we conducted comparative sequence analysis of MAPK proteins from the Theileria T. annulata, T. parva., T. orientalis, and T. equi and Babesia species B. bigemina, B. microti, and B. bovis . Three-dimensional protein structures from relevant species T. annulata and B. bovis were modelled and compounds were screened for interaction. Results showed that the inhibitors designed for human use could also be potent against Prioplasmida MAPKs. Furthermore, the structural differences between Prioplasmida and mammalian MAPKs could be a way for researchers to better instigate selective drug design.

🔖

Bu Makaleye Atıf Yap

MUTLU, Ö. (2020). Assessment of mitogen-activated protein kinases as therapeutic targets for the treatment of babesiosis and theileriosis. Turkish Journal of Veterinary and Animal Sciences, Cilt: 44 - Sayı: 3, 702–713. https://ajindex.com/articles/115311

Kaynakça (12)

  1. Bock R, Jackson L, de Vos A, Jorgensen W. Babesiosis of cattle. Parasitology 2004
  2. 129 (Suppl): S247-269. doi: 10.1017/ s0031182004005190 2. Bishop R, Musoke A, Morzaria S, Gardner M, Nene V. Theileria: intracellular protozoan parasites of wild and domestic ruminants transmitted by ixodid ticks. Parasitology 2004
  3. 129 (Suppl): S271-283. doi 10.1017/s0031182003004748 3. Rashid M, Akbar H, Rashid I, Saeed K, Ahmad L et al. Economic significance of tropical theileriosis ona holstein friesian dairy farm in Pakistan. Journal of Parasitology 2018
  4. 104 (3): 310-312. doi: 10.1645/16-179 4. Chatanga E, Mosssad E, Abubaker HA, Alnour SA, Katakura K et al. Evidence of multiple point mutations in Theileria annulata cytochrome b gene incriminated in buparvaquone treatment failure. Acta Tropica 2019
  5. doi: 10.1016/j.actatropica.2018.12.041 5. Suarez CE, Alzan HF, Silva MG, Rathinasamy V, Poole WA et al. Unravelling the cellular and molecular pathogenesis of bovine babesiosis: is the sky the limit? International Journal for Parasitology 2019
  6. 49 (2): 183-197. doi:10.1016/j. ijpara.2018.11.002 6. Mhadhbi M, Naouach A, Boumiza A, Chaabani MF, BenAbderazzak S et al. In vivo evidence for the resistance of Theileria annulata to buparvaquone. Veterinary Parasitology 2010
  7. doi: 10.1016/j. vetpar.2010.01.013 7. Sharifiyazdi H, Namazi F, Oryan A, Shahriari R, Razavi M. Point mutations in the Theileria annulata cytochrome b gene is associated with buparvaquone treatment failure. Veterinary Parasitology 2012
  8. doi: 10.1016/j. vetpar.2012.01.016 8. Mosqueda J, Olvera-Ramirez A, Aguilar-Tipacamu G, Canto GJ. Current advances in detection and treatment of babesiosis. Current Medicinal Chemistry 2012
  9. 19 (10): 1504- 1518. doi: 10.2174/092986712799828355 9. Plotnikov A, Zehorai E, Procaccia S, Seger R. The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochimica et Biophysica Acta 2011
  10. 1813 (9): 1619-1633. doi: 10.1016/j.bbamcr.2010.12.012 10. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002
  11. 298 (5600): 1912-1934. doi: 10.1126/science.1075762 11. Talevich E, Mirza A, Kannan N. Structural and evolutionary divergence of eukaryotic protein kinases in Apicomplexa. BMC Evolutionary Biology 2011
  12. doi: 10.1186/1471-2148- 11-321 12. Talevich E, Tobin AB, Kannan N, Doerig C. An evolutionary perspective on the kinome of malaria